CAR-T Cell Therapy Coming to Türkiye: Hope for Leukemia Patients
A groundbreaking development in cancer treatment is set to reach Turkey. A hospital run by the Foundation for Children with Leukemia (LÖSEV) is poised to introduce CAR-T cell therapy, a cutting-edge treatment for leukemia and other blood cancers. This therapy, which has shown promising results abroad, is considered a last resort for patients who do not respond to conventional treatments like chemotherapy or bone marrow transplants. In Spain, seven end-stage leukemia patients have responded positively to CAR-T therapy. The introduction of CAR-T therapy in Turkey could pave the way for further advancements. Experts believe it may contribute to the development of a cancer vaccine, bolstering both prevention and treatment efforts. This is particularly significant in Turkey, where leukemias are the most common cancers in children, affecting approximately 1,500 youngsters annually. CAR-T therapy works by reprogramming a patient's own immune cells. These cells are then trained to recognize and attack cancer cells, offering a potentially powerful weapon in the fight against these diseases. The Foundation for Children with Leukemia (LÖSEV) is set to introduce CAR-T cell therapy in Turkey. This breakthrough treatment offers hope to patients who have not responded to conventional treatments. Its introduction may also contribute to the development of a cancer vaccine, benefiting both prevention and treatment efforts in the country.
Read also:
- Comprehensive Overview of Addressing Traumatic Brain Injuries (TBIs)
- Enhanced Health Services Provisioned by San Diego Academic Health Partnership Continues During COVID-19 and Beyond
- Vaccination drive targeting infants under 6 months old against bronchiolitis in the region of Andalucia
- Biopsy Basics: Objectives, Varieties, and Potential Hazards - Healthline Illuminated
